These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations. Xu Y, Sun Y, Shen H, Ding L, Yang Z, Qiu H, Sun A, Chen S, Wu D. Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865 [Abstract] [Full Text] [Related]
3. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, Cayuela JM, Hayette S, Reman O, Contentin N, Bordessoule D, Pautas C, Botton Sd, Revel Td, Terre C, Fenaux P, Thomas X, Castaigne S, Dombret H, Preudhomme C. Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988 [Abstract] [Full Text] [Related]
7. Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia. Ibrahem L, Mahfouz R, Elhelw L, Abdsalam EM, Soliman R. Blood Cells Mol Dis; 2015 Jan; 54(1):84-9. PubMed ID: 25172541 [Abstract] [Full Text] [Related]
8. Aberrant hypomethylation of SALL4 gene is associated with intermediate and poor karyotypes in acute myeloid leukemia. Ma JC, Qian J, Lin J, Qian W, Yang J, Wang CZ, Chai HY, Li Y, Chen Q, Qian Z. Clin Biochem; 2013 Mar; 46(4-5):304-7. PubMed ID: 23201546 [Abstract] [Full Text] [Related]
9. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia. Zhu XW, Wen XM, Zhang YY, Yang L, Guo H, Yang J, Zhang M, Yin JY, Ma JC, Lin J, Deng ZQ, Qian J. Int J Clin Exp Pathol; 2015 Mar; 8(5):4321-31. PubMed ID: 26191124 [Abstract] [Full Text] [Related]
10. Methylation of CTNNA1 promoter: frequent but not an adverse prognostic factor in acute myeloid leukemia. Chen XX, Lin J, Qian J, Qian W, Yang J, Ma JC, Deng ZQ, An C, Tang CY, Qian Z, Liu Q. Leuk Res; 2014 May; 38(5):613-8. PubMed ID: 24685333 [Abstract] [Full Text] [Related]
11. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome. El Ghannam D, Taalab MM, Ghazy HF, Eneen AF. Blood Cells Mol Dis; 2014 May; 53(1-2):61-6. PubMed ID: 24512939 [Abstract] [Full Text] [Related]
13. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation. Hájková H, Marková J, Haškovec C, Sárová I, Fuchs O, Kostečka A, Cetkovský P, Michalová K, Schwarz J. Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068 [Abstract] [Full Text] [Related]
15. DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients. Shivarov V, Gueorguieva R, Stoimenov A, Tiu R. Leuk Res; 2013 Nov; 37(11):1445-50. PubMed ID: 23962568 [Abstract] [Full Text] [Related]
18. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia. Zhou JD, Zhang TJ, Wang YX, Yang DQ, Yang L, Ma JC, Wen XM, Yang J, Lin J, Qian J. Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961 [Abstract] [Full Text] [Related]